LSTA icon

Lisata Therapeutics
LSTA

Overview Fund Activity

28 hedge funds and large institutions have $4.25M invested in Lisata Therapeutics in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
-3
Holders Change %
-9.68%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
9
Reduced
6
Closed
5
Calls
$31K
Puts
$2K
Net Calls
+$29K
Net Calls Change
+$29K

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$1.27M
2
Geode Capital Management
2
Geode Capital Management
Massachusetts
$301K
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.27M
4
Deutsche Bank
4
Deutsche Bank
Germany
$56K
5
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$262K

Top Sellers

1
Macquarie Group
1
Macquarie Group
Australia
$95K
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$0
3
STA
3
Summit Trail Advisors
New York
$0
4
Ameriprise
4
Ameriprise
Minnesota
$115K
5
Millennium Management
5
Millennium Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
RE
26
RBC Europe
United Kingdom
$65 – – –
JPMorgan Chase & Co
27
JPMorgan Chase & Co
New York
– -$110K -1,251 Closed
STA
28
Summit Trail Advisors
New York
– -$73K -1,182 Closed
Millennium Management
29
Millennium Management
New York
– -$62K -708 Closed
1
2